Immunization programs for infants, children, adolescents and adults: clinical practice guidelines by the infectious diseases society of America

Larry K. Pickering, Carol J. Baker, Gary L. Freed, Stanley A. Gall, Stanley E. Grogg, Gregory A. Poland, Lance E. Rodewald, William Schaffner, Patricia Stinchfield, Litjen Tan, Richard K. Zimmerman, Walter A. Orenstein

Research output: Contribution to journalArticle

108 Citations (Scopus)

Abstract

Evidence-based guidelines for immunization of infants, children, adolescents, and adults have been prepared by an Expert Panel of the Infectious Diseases Society of America (IDSA). These updated guidelines replace the previous immunization guidelines published in 2002. These guidelines are prepared for health care professionals who care for either immunocompetent or immunocompromised people of all ages. Since 2002, the capacity to prevent more infectious diseases has increased markedly for several reasons: new vaccines have been licensed (human papillomavirus vaccine; live, attenuated influenza vaccine; meningococcal conjugate vaccine; rotavirus vaccine; tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis [Tdap] vaccine; and zoster vaccine), new combination vaccines have become available (measles, mumps, rubella and varicella vaccine; tetanus, diphtheria, and pertussis and inactivated polio vaccine; and tetanus, diphtheria, and pertussis and inactivated polio/Haemophilus influenzae type b vaccine), hepatitis A vaccines are now recommended universally for young children, influenza vaccines are recommended annually for all children aged 6 months through 18 years and for adults aged 5=50 years, and a second dose of varicella vaccine has been added to the routine childhood and adolescent immunization schedule. Many of these changes have resulted in expansion of the adolescent and adult immunization schedules. In addition, increased emphasis has been placed on removing barriers to immunization, eliminating racial/ethnic disparities, addressing vaccine safety issues, financing recommended vaccines, and immunizing specific groups, including health care providers, immunocompromised people, pregnant women, international travelers, and internationally adopted children. This document includes 46 standards that, if followed, should lead to optimal disease prevention through vaccination in multiple population groups while maintaining high levels of safety.

Original languageEnglish (US)
Pages (from-to)817-840
Number of pages24
JournalClinical Infectious Diseases
Volume49
Issue number6
DOIs
StatePublished - Sep 15 2009
Externally publishedYes

Fingerprint

Immunization Programs
Practice Guidelines
Communicable Diseases
Guidelines
Immunization Schedule
Immunization
Diphtheria
Vaccines
Whooping Cough
Influenza Vaccines
Tetanus
Poliomyelitis
Haemophilus Vaccines
Herpes Zoster Vaccine
Hepatitis A Vaccines
Acellular Vaccines
Meningococcal Vaccines
Chickenpox Vaccine
Rotavirus Vaccines
Diphtheria Toxoid

ASJC Scopus subject areas

  • Infectious Diseases
  • Microbiology (medical)

Cite this

Pickering, L. K., Baker, C. J., Freed, G. L., Gall, S. A., Grogg, S. E., Poland, G. A., ... Orenstein, W. A. (2009). Immunization programs for infants, children, adolescents and adults: clinical practice guidelines by the infectious diseases society of America. Clinical Infectious Diseases, 49(6), 817-840. https://doi.org/10.1086/605430

Immunization programs for infants, children, adolescents and adults : clinical practice guidelines by the infectious diseases society of America. / Pickering, Larry K.; Baker, Carol J.; Freed, Gary L.; Gall, Stanley A.; Grogg, Stanley E.; Poland, Gregory A.; Rodewald, Lance E.; Schaffner, William; Stinchfield, Patricia; Tan, Litjen; Zimmerman, Richard K.; Orenstein, Walter A.

In: Clinical Infectious Diseases, Vol. 49, No. 6, 15.09.2009, p. 817-840.

Research output: Contribution to journalArticle

Pickering, LK, Baker, CJ, Freed, GL, Gall, SA, Grogg, SE, Poland, GA, Rodewald, LE, Schaffner, W, Stinchfield, P, Tan, L, Zimmerman, RK & Orenstein, WA 2009, 'Immunization programs for infants, children, adolescents and adults: clinical practice guidelines by the infectious diseases society of America', Clinical Infectious Diseases, vol. 49, no. 6, pp. 817-840. https://doi.org/10.1086/605430
Pickering, Larry K. ; Baker, Carol J. ; Freed, Gary L. ; Gall, Stanley A. ; Grogg, Stanley E. ; Poland, Gregory A. ; Rodewald, Lance E. ; Schaffner, William ; Stinchfield, Patricia ; Tan, Litjen ; Zimmerman, Richard K. ; Orenstein, Walter A. / Immunization programs for infants, children, adolescents and adults : clinical practice guidelines by the infectious diseases society of America. In: Clinical Infectious Diseases. 2009 ; Vol. 49, No. 6. pp. 817-840.
@article{e309c9ec8382477d8f490608a25cdac4,
title = "Immunization programs for infants, children, adolescents and adults: clinical practice guidelines by the infectious diseases society of America",
abstract = "Evidence-based guidelines for immunization of infants, children, adolescents, and adults have been prepared by an Expert Panel of the Infectious Diseases Society of America (IDSA). These updated guidelines replace the previous immunization guidelines published in 2002. These guidelines are prepared for health care professionals who care for either immunocompetent or immunocompromised people of all ages. Since 2002, the capacity to prevent more infectious diseases has increased markedly for several reasons: new vaccines have been licensed (human papillomavirus vaccine; live, attenuated influenza vaccine; meningococcal conjugate vaccine; rotavirus vaccine; tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis [Tdap] vaccine; and zoster vaccine), new combination vaccines have become available (measles, mumps, rubella and varicella vaccine; tetanus, diphtheria, and pertussis and inactivated polio vaccine; and tetanus, diphtheria, and pertussis and inactivated polio/Haemophilus influenzae type b vaccine), hepatitis A vaccines are now recommended universally for young children, influenza vaccines are recommended annually for all children aged 6 months through 18 years and for adults aged 5=50 years, and a second dose of varicella vaccine has been added to the routine childhood and adolescent immunization schedule. Many of these changes have resulted in expansion of the adolescent and adult immunization schedules. In addition, increased emphasis has been placed on removing barriers to immunization, eliminating racial/ethnic disparities, addressing vaccine safety issues, financing recommended vaccines, and immunizing specific groups, including health care providers, immunocompromised people, pregnant women, international travelers, and internationally adopted children. This document includes 46 standards that, if followed, should lead to optimal disease prevention through vaccination in multiple population groups while maintaining high levels of safety.",
author = "Pickering, {Larry K.} and Baker, {Carol J.} and Freed, {Gary L.} and Gall, {Stanley A.} and Grogg, {Stanley E.} and Poland, {Gregory A.} and Rodewald, {Lance E.} and William Schaffner and Patricia Stinchfield and Litjen Tan and Zimmerman, {Richard K.} and Orenstein, {Walter A.}",
year = "2009",
month = "9",
day = "15",
doi = "10.1086/605430",
language = "English (US)",
volume = "49",
pages = "817--840",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - Immunization programs for infants, children, adolescents and adults

T2 - clinical practice guidelines by the infectious diseases society of America

AU - Pickering, Larry K.

AU - Baker, Carol J.

AU - Freed, Gary L.

AU - Gall, Stanley A.

AU - Grogg, Stanley E.

AU - Poland, Gregory A.

AU - Rodewald, Lance E.

AU - Schaffner, William

AU - Stinchfield, Patricia

AU - Tan, Litjen

AU - Zimmerman, Richard K.

AU - Orenstein, Walter A.

PY - 2009/9/15

Y1 - 2009/9/15

N2 - Evidence-based guidelines for immunization of infants, children, adolescents, and adults have been prepared by an Expert Panel of the Infectious Diseases Society of America (IDSA). These updated guidelines replace the previous immunization guidelines published in 2002. These guidelines are prepared for health care professionals who care for either immunocompetent or immunocompromised people of all ages. Since 2002, the capacity to prevent more infectious diseases has increased markedly for several reasons: new vaccines have been licensed (human papillomavirus vaccine; live, attenuated influenza vaccine; meningococcal conjugate vaccine; rotavirus vaccine; tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis [Tdap] vaccine; and zoster vaccine), new combination vaccines have become available (measles, mumps, rubella and varicella vaccine; tetanus, diphtheria, and pertussis and inactivated polio vaccine; and tetanus, diphtheria, and pertussis and inactivated polio/Haemophilus influenzae type b vaccine), hepatitis A vaccines are now recommended universally for young children, influenza vaccines are recommended annually for all children aged 6 months through 18 years and for adults aged 5=50 years, and a second dose of varicella vaccine has been added to the routine childhood and adolescent immunization schedule. Many of these changes have resulted in expansion of the adolescent and adult immunization schedules. In addition, increased emphasis has been placed on removing barriers to immunization, eliminating racial/ethnic disparities, addressing vaccine safety issues, financing recommended vaccines, and immunizing specific groups, including health care providers, immunocompromised people, pregnant women, international travelers, and internationally adopted children. This document includes 46 standards that, if followed, should lead to optimal disease prevention through vaccination in multiple population groups while maintaining high levels of safety.

AB - Evidence-based guidelines for immunization of infants, children, adolescents, and adults have been prepared by an Expert Panel of the Infectious Diseases Society of America (IDSA). These updated guidelines replace the previous immunization guidelines published in 2002. These guidelines are prepared for health care professionals who care for either immunocompetent or immunocompromised people of all ages. Since 2002, the capacity to prevent more infectious diseases has increased markedly for several reasons: new vaccines have been licensed (human papillomavirus vaccine; live, attenuated influenza vaccine; meningococcal conjugate vaccine; rotavirus vaccine; tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis [Tdap] vaccine; and zoster vaccine), new combination vaccines have become available (measles, mumps, rubella and varicella vaccine; tetanus, diphtheria, and pertussis and inactivated polio vaccine; and tetanus, diphtheria, and pertussis and inactivated polio/Haemophilus influenzae type b vaccine), hepatitis A vaccines are now recommended universally for young children, influenza vaccines are recommended annually for all children aged 6 months through 18 years and for adults aged 5=50 years, and a second dose of varicella vaccine has been added to the routine childhood and adolescent immunization schedule. Many of these changes have resulted in expansion of the adolescent and adult immunization schedules. In addition, increased emphasis has been placed on removing barriers to immunization, eliminating racial/ethnic disparities, addressing vaccine safety issues, financing recommended vaccines, and immunizing specific groups, including health care providers, immunocompromised people, pregnant women, international travelers, and internationally adopted children. This document includes 46 standards that, if followed, should lead to optimal disease prevention through vaccination in multiple population groups while maintaining high levels of safety.

UR - http://www.scopus.com/inward/record.url?scp=70049089247&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70049089247&partnerID=8YFLogxK

U2 - 10.1086/605430

DO - 10.1086/605430

M3 - Article

C2 - 19659433

AN - SCOPUS:70049089247

VL - 49

SP - 817

EP - 840

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 6

ER -